Al-Dawaa Medical Services Company
TADAWUL:4163.SR
95 (SAR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 5,741.364 | 5,372.243 | 5,034.382 | 4,962.077 | 3,962.427 | 3,797.197 | 3,375.626 |
| Cost of Revenue
| 3,634.745 | 3,352.644 | 3,139.978 | 3,389.945 | 2,405.331 | 2,350.992 | 2,087.865 |
| Gross Profit
| 2,106.619 | 2,019.598 | 1,894.404 | 1,572.132 | 1,557.095 | 1,446.206 | 1,287.76 |
| Gross Profit Ratio
| 0.367 | 0.376 | 0.376 | 0.317 | 0.393 | 0.381 | 0.381 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 41.739 | 52.218 | 51.562 | 102.902 | 90.152 | 85.818 | 62.484 |
| Selling & Marketing Expenses
| 227.385 | 211.754 | 207.674 | 1,350.268 | 1,157.122 | 1,054.62 | 990.599 |
| SG&A
| 269.124 | 263.972 | 259.235 | 1,174.132 | 1,256.484 | 1,151.43 | 1,077.395 |
| Other Expenses
| -1,639.929 | -0.664 | -8.106 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1,639.929 | 1,645.251 | 1,621.368 | 1,174.132 | 1,234.727 | 1,147.212 | 1,082.926 |
| Operating Income
| 466.69 | 369.039 | 267.893 | 398 | 300.612 | 294.776 | 210.366 |
| Operating Income Ratio
| 0.081 | 0.069 | 0.053 | 0.08 | 0.076 | 0.078 | 0.062 |
| Total Other Income Expenses Net
| -466.69 | -51.169 | -21.875 | -136.906 | -56.637 | -65.136 | -67.149 |
| Income Before Tax
| 342.404 | 317.87 | 246.018 | 261.094 | 243.975 | 229.64 | 143.217 |
| Income Before Tax Ratio
| 0.06 | 0.059 | 0.049 | 0.053 | 0.062 | 0.06 | 0.042 |
| Income Tax Expense
| 13.18 | 12.421 | 6.873 | 14.658 | 10.771 | 1.31 | 22.321 |
| Net Income
| 329.223 | 305.449 | 239.145 | 246.435 | 233.204 | 228.331 | 120.896 |
| Net Income Ratio
| 0.057 | 0.057 | 0.048 | 0.05 | 0.059 | 0.06 | 0.036 |
| EPS
| 3.87 | 3.59 | 2.81 | 2.9 | 1,166.02 | 0 | 0 |
| EPS Diluted
| 3.87 | 3.59 | 2.81 | 2.9 | 1,166.02 | 0 | 0 |
| EBITDA
| 837.363 | 732.087 | 596.278 | 707.128 | 447.311 | 431.269 | 340.21 |
| EBITDA Ratio
| 0.146 | 0.136 | 0.118 | 0.143 | 0.113 | 0.114 | 0.101 |